New Duchenne treatment approved for use in Scotland

Scottish Medicines Consortium (SMC) has approved the treatment givinostat for use on the NHS in Scotland, for children aged 6+ who are still able to walk at the start of treatment. Givinostat (also known by its brand name Duvyzat) was approved for market authorisation...

Duchenne community campaigns for givinostat

The UK’s National Institute for Health and Care Excellence (NICE) has announced it will seek further guidance on whether new treatment givinostat should be made routinely available on the NHS. NICE held its initial committee meeting to appraise the drug in July,...